the capability and compliance of the site and staff:

• Delegation of Authority Log
• Site Training Logs
• Good Clinical Practice (GCP) Training Certificates
• Site Infrastructure Questionnaire
• Laboratory Accreditation Certificates
• Normal Lab Ranges and Sample Handling SOPs

Study-Specific Documents:

1. Informed Consent Forms (ICFs) – All approved versions in local language(s)
2. Patient Information Sheets (PIS)
3. Recruitment Materials – Flyers, posters, or online ads used for subject enrollment
4. Randomization Instructions – If applicable to the trial
5. Case Report Forms (CRFs) and eCRF access instructions

Ethics and Regulatory Submissions:

All documentation sent to and approved by the Institutional Review Board (IRB)/Ethics Committee (EC) should be retained and tracked. As per CDSCO and ICH GCP guidelines:

• Initial EC/IRB Approval Letter
• Continuing Review Approvals
• Study Amendments Approvals
• Correspondence Logs with EC/IRB

Administrative and Logistical Documents:

Other documents required to ensure administrative readiness include:

1. Site Activation Letter
2. Start-up Meeting Minutes
3. Site Initiation Visit Report
4. Drug Shipment Authorization and Receipt Logs
5. Site-Specific SOP Acknowledgements

Best Practices for Managing Document Collection:

Managing dozens of documents across multiple sites requires a systematic approach:

• Use a regulatory document tracker with version control
• Conduct regular document QC and completeness checks
• Implement SOPs for document flow, filing, and storage
• Use electronic Trial Master File (eTMF) systems where possible
• Create timelines with due dates and responsible persons assigned

Following SOPs found on platforms like Pharma SOP templates ensures streamlined compliance.

Document Readiness Before Site Initiation Visit (SIV):

Before the Site Initiation Visit can be conducted, the following should be in place:

1. All IRB approvals documented and filed
2. Sponsor green light for activation
3. Site staff trained and documented
4. Complete ISF as per checklist

Document gaps are among the most common causes of SIV delays and audit findings.

Maintaining and Archiving Essential Documents:

Document control does not end with study initiation. Long-term compliance includes:

• Timely updates to logs and certifications
• Secure archiving for at least 2 years post-marketing or per local law
• Periodic audits of ISF and TMF for completeness and accuracy
• Retraining staff on documentation SOPs annually

Conclusion:

The document collection process for study initiation is a critical step in launching compliant, high-quality clinical trials. A clear checklist, timely communication with sites, and adherence to regulatory standards ensure that no document is missed. Leveraging platforms like Stability Studies for checklist guidance and maintaining a proactive documentation culture are key to audit readiness and operational success.